In the News

Line Art 1
Line Art 2
Line Art 3
Line Art 4

Prescryptive Health Announces New Language Capabilities to Increase Patient Accessibility

As part of a multi-language strategy to make healthcare work for everyone, Prescryptive Health launches Spanish language access…

FTC action on PBMs could be just what the doctor ordered to improve patient outcomes

The FTC’s investigation into the business practices of PBMs could expose the outsized influence PBMs have on access…

As Seen In: Drug Topics

Best of Total Pharmacy in 2022

Take a look back at the most popular Total Pharmacy coverage for 2022, including the NCPA recommendation of…

As Seen In: HIT Consultant

Prescryptive Health Taps Lilly on First-to-Market Value-Based Program to Stabilize Insulin Pricing

Prescryptive Health partnered with Eli Lilly and Company on a new subscription model to help lower costs for…

As Seen In: Formulary Watch

Prescryptive Health Partners with Lilly for Insulin Program

Prescryptive Health has partnered with Eli Lilly to create a subscription-based insulin program for employers that aims to…

As Seen In: Healthcare Americana

PODCAST: Prescryptive’s Chris Blackley on Prescription Drug Market Transparency

Prescryptive CEO, Chris Blackley, joins the Healthcare Americana podcast to discuss the root of the prescription drug pricing…

As Seen In: Pharmacy Times

5 Hot Topics for Community Pharmacists in 2023

With a new year on the way, pharmacists have so much to be grateful for, and a world…

As Seen In: BenefitsPRO

IRA means increased drug prices for commercial plans: Ways to prepare

Drug prices for commercial health plans could increase under the recently passed Inflation Reduction Act. HR must act…

As Seen In: Pharmacy Times

Prepare for Impact: How the Right Technology Can Energize the Pharmacy Experience

In our recent Independent Pharmacy Trends study, we found that more than 90% of independent pharmacy customers want technology to…

As Seen In: MedCity News

Pharmacy benefit managers inflate drug prices and decrease competition while consumers pay the price. Does the FTC have the medicine to fix it?

Our CEO Chris Blackley writes in MedCity News about the FTC’s new probe into the big pharmacy benefit…

As Seen In: Forbes

Drug Price Transparency Stymies Consumers, New Survey Shows

As Deb Gordon writes in Forbes about our Pharmacy Trends survey, “…90% of survey respondents said they would appreciate…

As Seen In: Drug Topics

NCPA Annual Convention and Expo: Prescryptive Health

See highlights for the annual NCPA convention in Kansas City, including sessions from Prescryptive Health! Conference Preview: NCPA Annual…